Back

Estimating the effect of lipids on IGF axis and subsequent breast cancer risk

Tan, V. Y.; Bull, C. J.; Biernacka, K. M.; Teumer, A. J.; Corbin, L.; Dudding, T.; Sanderson, E.; Qi, Q.; Kaplan, R.; Rotter, J.; Friedrich, N.; Volker, U.; Mayerle, J.; Perks, C. M.; Holly, J. M.; Timpson, N. J.

2020-06-07 oncology
10.1101/2020.06.04.20122630
Show abstract

Circulating lipids have been associated with breast cancer (BCa). This association may, in part, be due to an effect of lipids on insulin-like growth factors (IGFs), which have been reliably associated with BCa. In two-sample Mendelian randomization (MR) analyses, we found that low density lipoprotein (LDL-C) was associated with IGFBP-3 (beta:0.08 SD; 95%CI:0.02,0.15; p = 0.01, per SD increase in LDL-C) and IGFBP-3 was associated with postmenopausal BCa (OR:1.09; 95%CI:1.00,1.19; p = 0.05, per SD increase in IGFBP-3). We also found that triglycerides were associated with IGF-I (beta:-0.13SD; 95%CI:-0.22,-0.03, per SD increase in triglycerides) and that IGF-I was associated with overall BCa (OR:1.10;95%CI:1.02,1.18, per SD increase in IGF-I). Taken together, these results suggest that IGFBP-3 may be a potential causal step between LDL-C and postmenopausal BCa and IGF-I a potential causal for triglycerides. Our two-step MR results build on evidence linking circulating lipids and IGFs with BCa, however, multivariable MR analyses are currently unable to support this relationship due to weak instruments.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 31%
15.7%
2
Breast Cancer Research
based on 11 papers
Top 0.1%
12.8%
3
Cancer Epidemiology, Biomarkers & Prevention
based on 14 papers
Top 0.2%
5.4%
4
British Journal of Cancer
based on 22 papers
Top 0.6%
5.4%
5
Cancers
based on 57 papers
Top 3%
4.6%
6
Cancer Medicine
based on 17 papers
Top 0.7%
4.6%
7
eLife
based on 262 papers
Top 5%
4.6%
50% of probability mass above
8
The Journal of Clinical Endocrinology & Metabolism
based on 26 papers
Top 2%
3.0%
9
Scientific Reports
based on 701 papers
Top 50%
3.0%
10
JAMA Network Open
based on 125 papers
Top 5%
3.0%
11
Nature Communications
based on 483 papers
Top 22%
2.9%
12
BMC Medicine
based on 155 papers
Top 7%
2.6%
13
BMJ Open
based on 553 papers
Top 37%
2.3%
14
International Journal of Cancer
based on 18 papers
Top 0.8%
2.3%
15
JNCI: Journal of the National Cancer Institute
based on 13 papers
Top 1%
1.6%
16
PeerJ
based on 46 papers
Top 5%
1.6%
17
JCO Precision Oncology
based on 11 papers
Top 2%
1.4%
18
Proceedings of the National Academy of Sciences
based on 100 papers
Top 9%
1.4%
19
Clinical Cancer Research
based on 22 papers
Top 3%
1.4%
20
BMC Cancer
based on 21 papers
Top 4%
1.2%
21
Journal of Personalized Medicine
based on 17 papers
Top 1%
1.2%
22
PLOS Medicine
based on 95 papers
Top 14%
0.8%
23
iScience
based on 74 papers
Top 7%
0.8%
24
Frontiers in Oncology
based on 34 papers
Top 5%
0.8%
25
Journal of Clinical Epidemiology
based on 29 papers
Top 3%
0.7%
26
International Journal of Epidemiology
based on 65 papers
Top 10%
0.7%